In order to commence workplace learning outside of the University of Tasmania (including clinical placements and visits) you will be required to demonstrate compliance with the Faculty of Health Science and the School of Medicine's policies relevant to workplace based learning. These include the Police Check Policy and Procedures, Infectious Disease Policy, Code of Conduct and Student Placement Agreement. Students who do not comply with these policies will not be placed or will be removed from placements and unable to attend hospital rounds and therefore will not be able to complete this unit. Students who have not complied or are unsure of the policies should seek guidance from the School.
CSA306 Therapeutics in Practice 3B builds upon students existing knowledge of physiology, pharmacology and microbiology, in order to develop the clinical knowledge and skills necessary to deliver pharmaceutical care.
Topics include the pathophysiology and therapeutic principles used in the management of common diseases. These include neurological, psychiatric, gastrointestinal, hepatic and rheumatological conditions; as well as more complex multiple disease states. An emphasis is placed on the application of knowledge to evaluate and advise upon pharmacotherapy in clinical situations. Skills will be developed for application in the practice setting, including clinical pharmacy skills, pharmaceutical care, patient monitoring (including review of laboratory data) and identification and resolution of drug related problems. Teaching activities will include lectures and tutorials with case studies and are supported by clinical rounds and tutorials at the Royal Hobart Hospital where your knowledge will be applied to solving real world drug-related problems.
|Unit name||Therapeutics in Practice 3B|
|Faculty/School||College of Health and Medicine
Tasmanian School of Medicine
Mr Angus Thompson, Mr Michael Connolly, Mr Justin Cousins
|Available as student elective?||No|
Please check that your computer meets the minimum System Requirements if you are attending via Distance/Off-Campus.
Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.
Special approval is required for enrolment into TNE Program units.
TNE Program units special approval requirements.
* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (see withdrawal dates explained for more information).
4 hours of lectures and 2 hours of tutorials each week for 10 weeks of semester, plus four hospital-based clinical rounds/tutorials.
1 mid-semester written test (20%), 1 end of semester oral exam (15%), 1 medication management plan assessment (10%) and 1 x 2-hr end of semester written exam (55%).
The final mark for CSA306 is an aggregate based on the weighted marks from CSA322 (2/3) and CSA306 (1/3).
A student must achieve ≥50% in the end of year (CSA306) written exam plus an overall aggregate mark of ≥50% to pass CSA322 and CSA306.
|Timetable||View the lecture timetable | View the full unit timetable|
Information about any textbook requirements will be available from mid November.
The University reserves the right to amend or remove courses and unit availabilities, as appropriate.